Cryptocurrency, Web3, Distributed Ledger Technologies (DLT), and Decentralised Finance (DeFi) in Financial Services Training Course (ONLINE EVENT: September 10-12, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Navigate DeFi, Blockchain, and Digital Transformation in Financial Services” training has been added to ResearchAndMarkets.com’s... Read more.
Mogo Monetizes $13.8 Million of WonderFi Stake and Increases Bitcoin Holdings
Proceeds Represent Just Under 50% of Total Position; Transaction Precedes Expected Closing of WonderFi – Robinhood Acquisition in Second Half of 2025 VANCOUVER,... Read more.
Extracellular Vesicles/Exosomes Asia Conference 2025 Discover Emerging Diagnostic and Therapeutic Applications of Extracellular Vesicles (Tokyo, Japan – October 6-7, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Extracellular Vesicles/Exosomes Asia 2025” conference has been added to ResearchAndMarkets.com’s offering.... Read more.
Adnan Al Faraj Appointed Head of SME Direct Lending of ZCG Arabia
Builds on Firm’s Commitment to Invest in Saudi Arabia NEW YORK–(BUSINESS WIRE)–Z Capital Group (“ZCG”), a leading, privately held global firm,... Read more.
Lincoln Electric Acquires Remaining Interest in Alloy Steel
Acquisition Expands Lincoln Electric’s Portfolio of Proprietary Maintenance and Repair Solutions with the Addition of New Wear Plate Technologies and Engineering... Read more.
Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement
— Heinley to focus on strategic growth, and joins the leadership team of Sam Brown, a Blue Matter Company — WAYNE, Pa. & NEW YORK–(BUSINESS... Read more.
Revive® Infrastructure Group Strengthens Senior Leadership Team with Key Hire and Promotion
Strategic Moves Bolster Operational Excellence and Drive Business Growth PACIFIC, Mo.–(BUSINESS WIRE)–#crownutilitiesllc—Revive Infrastructure... Read more.
CommScope Reports Second Quarter 2025 Results
Second Quarter Highlights Net sales of $1.39 billion GAAP income from continuing operations of $29.4 million Non-GAAP adjusted EBITDA of $337.8 million (1) Cash... Read more.
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results... Read more.
Drug Farm Announces First Patients Dosed in Phase 1b Clinical Trial Evaluating ALPK1 Inhibitor, DF-003 in ROSAH Syndrome
Trial will evaluate DF-003, a first-in-class ALPK1 inhibitor that specifically targets the genetic root cause of ROSAH syndrome ALBANY, N.Y. & SHANGHAI–(BUSINESS... Read more.